Left ventricular noncompaction cardiomyopathy
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
39
|
28
|
0.100 |
None |
|
0 |
1
|
|
|
Ventricular Arrhythmia, CTCAE 3.0
|
phenotype |
|
Finding
|
17
|
|
0.100 |
None |
|
0 |
|
|
|
Sudden Cardiac Death
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
133
|
40
|
0.100 |
None |
|
0 |
|
|
|
Ventricular Arrhythmia, CTCAE 5.0
|
phenotype |
|
Finding
|
17
|
|
0.100 |
None |
|
0 |
|
|
|
Right ventricular cardiomyopathy
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
15
|
4
|
0.100 |
None |
|
0 |
|
|
|
Vertigo
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Sign or Symptom
|
173
|
35
|
0.100 |
None |
|
0 |
|
|
|
Electrocardiogram change
|
phenotype |
|
Finding
|
18
|
27
|
0.100 |
None |
|
0 |
2
|
|
|
Dilatation of the ventricular cavity
|
phenotype |
Cardiovascular Diseases
|
Anatomical Abnormality
|
6
|
2
|
0.100 |
None |
|
0 |
|
|
|
Ventricular Arrhythmia by ECG Finding
|
phenotype |
|
Laboratory or Test Result
|
17
|
|
0.100 |
None |
|
0 |
|
|
|
Tachyarrhythmia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Finding
|
18
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Tachycardia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Finding
|
73
|
8
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Malignant mesothelioma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
420
|
12
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Diabetic Cardiomyopathies
|
disease |
Endocrine System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
220
|
1
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Myocardial Ischemia
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
756
|
103
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Other cardiomyopathies
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
4
|
|
0.200 |
None |
1.000 |
1 |
|
2006 |
2006 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Ventricular Fibrillation
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
96
|
19
|
0.110 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Serum LDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
269
|
555
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Schizophrenia, Childhood
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
33
|
20
|
0.100 |
None |
1.000 |
1 |
2
|
2016 |
2016 |
Narcolepsy
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
308
|
454
|
0.100 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Adolescent idiopathic scoliosis
|
disease |
Musculoskeletal Diseases
|
Anatomical Abnormality
|
656
|
1178
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3
|
disease |
|
Finding
|
578
|
1158
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Forced expiratory volume function
|
phenotype |
|
Organ or Tissue Function
|
272
|
1169
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Rhabdomyolysis
|
phenotype |
Musculoskeletal Diseases
|
Pathologic Function
|
36
|
15
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |